Literature DB >> 20358170

[Thyroid diseases and hypertension].

C Spitzweg1, M Reincke.   

Abstract

Thyroid hormones have several well-recognized effects on the vasculature and heart, resulting in characteristic cardiovascular changes in thyroid disease, including an increase in blood pressure. In hyperthyroidism reduced systemic vascular resistance and increased blood volume lead to an enhanced preload, which, in association with reduced afterload, improved contractility, as well as increased beta-adrenergic activity, results in isolated systolic hypertension based on enhanced stroke volume and cardiac output. In contrast, hypothyroidism causes increased systemic vascular resistance in association with decreased arterial compliance resulting in elevated diastolic blood pressure. Therefore in the evaluation of arterial hypertension secondary hypertension based on thyroid disease should always be considered, especially given the fact that blood pressure changes in the course of thyroid dysfunction are usually reversible upon adequate treatment of hypo- or hyperthyroidism.

Entities:  

Mesh:

Year:  2010        PMID: 20358170     DOI: 10.1007/s00108-009-2499-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  36 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension.

Authors:  D H Streeten; G H Anderson; T Howland; R Chiang; H Smulyan
Journal:  Hypertension       Date:  1988-01       Impact factor: 10.190

3.  Subclinical thyroid dysfunction and blood pressure: a community-based study.

Authors:  John P Walsh; Alexandra P Bremner; Max K Bulsara; Peter O'Leary; Peter J Leedman; Peter Feddema; Valdo Michelangeli
Journal:  Clin Endocrinol (Oxf)       Date:  2006-10       Impact factor: 3.478

4.  Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study.

Authors:  J V Parle; P Maisonneuve; M C Sheppard; P Boyle; J A Franklyn
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

5.  Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes.

Authors:  Z Q Sun; K Ojamaa; W A Coetzee; M Artman; I Klein
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-02       Impact factor: 4.310

6.  The evaluation of left ventricular hypertrophy in hypertensive patients with subclinical hyperthyroidism.

Authors:  Ismet Tamer; Mehmet Sargin; Haluk Sargin; Mesut Seker; Erhan Babalik; Mustafa Tekce; Ali Yayla
Journal:  Endocr J       Date:  2005-08       Impact factor: 2.349

7.  Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase.

Authors:  H Mizuma; M Murakami; M Mori
Journal:  Circ Res       Date:  2001-02-16       Impact factor: 17.367

8.  The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area.

Authors:  Henry Völzke; Jan Lüdemann; Daniel M Robinson; Knut W Spieker; Christian Schwahn; Axel Kramer; Ulrich John; Wieland Meng
Journal:  Thyroid       Date:  2003-08       Impact factor: 6.568

Review 9.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

10.  Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality.

Authors:  Nicolas Ochs; Reto Auer; Douglas C Bauer; David Nanchen; Jacobijn Gussekloo; Jacques Cornuz; Nicolas Rodondi
Journal:  Ann Intern Med       Date:  2008-05-19       Impact factor: 25.391

View more
  2 in total

1.  TRANSCRIPTION FACTOR GLI-SIMILAR 3 (GLIS3): IMPLICATIONS FOR THE DEVELOPMENT OF CONGENITAL HYPOTHYROIDISM.

Authors:  Kristin Lichti-Kaiser; Gary ZeRuth; Anton M Jetten
Journal:  J Endocrinol Diabetes Obes       Date:  2014-04

Review 2.  [Thyroid emergencies : Thyroid storm and myxedema coma].

Authors:  C Spitzweg; M Reincke; R Gärtner
Journal:  Internist (Berl)       Date:  2017-10       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.